SCHEMBL25565730

SCHEMBL25565730

CC(C)Oc1ccc(C(C)(c2ccc(OC(C)C)cc2)c2ccc(OC(C)C)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A3 P47895 1/20 0.48
PTPN5 P54829 1/20 0.47
KMT2A Q03164 3/20 0.47
PARP10 Q53GL7 1/20 0.45
NR1H4 Q96RI1 1/20 0.45
POLB P06746 1/20 0.42
GLA P06280 1/20 0.41
CYP3A4 P08684 2/20 0.41
CYP3A5 P20815 2/20 0.41
ALDH1A1 P00352 4/20 0.40
LMNA P02545 2/20 0.40
TP53 P04637 2/20 0.40
MAPK1 P28482 1/20 0.40
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
ALPL P05186 1/20 0.38
ALPI P09923 1/20 0.38
ALPG P10696 1/20 0.38
CYP1A2 P05177 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12541779 0.90 ESR1 (0.53) ALDH1A3PTPN5KMT2APARP10NR1H4
SCHEMBL10934190 0.86 ALDH1A3 (0.48) ALDH1A3PTPN5KMT2APARP10NR1H4
SCHEMBL799946 0.86 NR1H4 (0.57) ALDH1A3PTPN5KMT2APARP10NR1H4
SCHEMBL21524819 0.82 MAPT (0.38) ALDH1A3PTPN5KMT2APARP10NR1H4
SCHEMBL11544763 0.82 PTPN5 (0.49) ALDH1A3PTPN5KMT2APARP10NR1H4
SCHEMBL125543 0.82 ALDH1A3 (0.64) ALDH1A3PTPN5KMT2APARP10POLB
SCHEMBL13283362 0.80 NR1H4 (0.53) ALDH1A3PTPN5KMT2APARP10NR1H4
SCHEMBL17404857 0.80 PTPN5 (0.56) ALDH1A3PTPN5KMT2APARP10NR1H4
SCHEMBL178405 0.79 CYP3A4 (0.58) ALDH1A3PTPN5KMT2APARP10CYP3A4
SCHEMBL12807710 0.79 NPC1 (0.55) ALDH1A3PTPN5KMT2ANR1H4POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230149562-A1 CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY TIBA BIOTECH LLC (US) 2023-05-18 US disclosed
US-20230149562-A1 CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY TIBA BIOTECH LLC (US) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230149562-A1 CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY POLN, TLR9, TSG101 ALDH1A3 3711/4885PTPN5 3204/4885KMT2A 4317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.